Oklo stock (OKLO) fell on Tuesday after the nuclear start-up released its second-quarter results. While the numbers met expectations, investors seem to be waiting for clearer updates on when the company will open its first commercial plant.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Oklo’s Loss Narrows but Launch Is Still Years Away
Oklo reported a net loss of $24.7 million, or 18 cents a share, in the second quarter. That was smaller than the $27.3 million loss, or 27 cents a share, a year ago. The company said cash use was in line with plans and confirmed it is aiming to start commercial operations between late 2027 and early 2028.
“There’s a growing consensus that nuclear power is fundamental to the country’s energy future, but historically, costs and time delays have held it back,” CEO Jacob DeWitte said on the earnings call, echoing sentiment from an earlier interview with Barron’s. “One of the reasons we’re in a strong position today is the disciplined approach we’ve taken to design and cost engineering from the outset.”
This shows Oklo’s confidence in its careful and cost-focused strategy. But with the launch still several years away, some investors may be cautious until there is more progress.
Analysts Stay Positive on OKLO Stock
Despite the drop, analysts remain upbeat. Wedbush kept its Outperform rating on the stock and raised its price target to $80 from $75. Lead analyst Daniel Ives said Oklo could benefit from the Trump administration’s support for nuclear power, noting the start-up has “key allies in the White House.”
Wedbush has supported Oklo’s plan to build, own, and operate its own nuclear plants as a way to create steady revenue and keep control of its assets.
Is OKLO Stock a Good Buy?
According to TipRanks, 13 analysts have rated Oklo in the past three months, resulting in nine Buys, three Holds, and one Sell recommendation. This gives the stock a consensus rating of Moderate Buy. The average 12-month OKLO price target is $63.78, about 15% below Oklo’s latest close of $75.32.
Even with strong support from analysts, the stock slipped as the market looked for new milestones. Oklo has not yet made a profit and is still working through the approval process for its first plant at Idaho National Laboratory.
OKLO shares were down 1.6% to $70.73 in premarket trading, while S&P 500 futures were flat, suggesting the drop was driven by company news rather than the overall market.
